Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Neurological and cognitive problems news


From To
Previous Syphilis Infection Might Cause Poorer Brain Function for People With HIV

HIV-positive people who have been infected with syphilis (Treponema pallidum) in the past might have poorer brain function than HIV-positive people who have never had it. These data were presented Monday, February 28, at the 18th Conference on Retroviruses and Opportunistic Infections (CROI) in Boston.

01 March 2011
Studying memory provides clues for helping the brain

Researchers have unexpectedly found that some older HIV-positive adults had better assessments of working memory than younger HIV-positive adults.

18 February 2011
Can I exercise to ease my neuropathy?

Exercise may help with peripheral neuropathy, but be sure to avoid high-impact workouts.

12 January 2011
The Advocate
Abstinence, heavy drinking, binge drinking associated with increased risk of cognitive impairment

(IOS Press) Previous research regarding the association between alcohol consumption and dementia or cognitive impairment in later life suggests that mild to moderate alcohol consumption might be protective of dementia. However, most of the research has been conducted on subjects already rather elderly at the start of the follow-up. A new study published in the December issue of the Journal of Alzheimer's Disease addresses this problem with a follow-up of more than two decades.

10 January 2011
Eurekalert Medicine & Health
HIV Reservoir in the Brain Doesn’t Respond to Treatment Intensification

Adding a new antiretroviral (ARV) drug with the ability to penetrate into the brain to an existing regimen doesn’t reduce residual HIV in the brain or brain inflammation in people who have good suppression of HIV elsewhere in the body, according to a study published in the December 15 issue of the Journal of Acquired Immune Deficiency Syndromes. 

06 December 2010
Discordant HIV Levels in the Brain and Blood Are More Common Than Expected

Up to 10 percent of people on antiretroviral therapy have active HIV replication in the brain and spinal fluid despite having undetectable HIV levels in the blood, according to a new study.

16 November 2010
Updates from the 1st International Workshop on HIV & Aging

Nelson Vergel reports from the first international specialist meeting on diseases of ageing in people with HIV infection.

27 October 2010
The Body
Neurotune presents positive dimiracetam Phase IIa results for treatment of neuropathic pain in HIV-positive patients

Neurotune, a Swiss biopharmaceutical company, has presented positive top-line results from its phase IIa, safety and tolerability, study of dimiracetam (NT-11624), for treatment-induced neuropathic pain in HIV patients receiving anti-retroviral medication.

22 October 2010
Pharmaceutical Business Review
NeurogesX to pursue expanded U.S. label for Qutenza® (capsaicin) 8% patch in HIV-associated neuropathy

NeurogesX, a biopharmaceutical company focused on developing and commercializing novel pain management therapies, today announced plans to pursue a U.S. label expansion for Qutenza® (capsaicin) 8% patch to include patients with painful HIV-associated neuropathy (HIV-AN, also referred to as HIV-distal sensory polyneuropathy (HIV-DSP)).

18 October 2010
PR Newswire
Aging With Complex Chronic Disease: The Wrinkled Face of AIDS

People living with HIV taking combination Antiretroviral Therapy (treatment) are living long enough to experience a diverse array of aging related conditions such as osteoporosis, cardiovascular disease, chronic obstructive pulmonary disease (COPD), renal disease, liver cirrhosis, and cancer.

25 August 2010
The Body Pro / GMHC Treatment Issues
← Prev1...678910Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.